ITRM

Iterum Therapeutics plc Ordinary Share

0.30

USD

ITRM Earnings Reports

Positive Surprise Ratio

ITRM beat 17 of 29 last estimates.

59%

Next Report

Date of Next Report

May 11, 2026

Estimate for Q1 26 (Revenue/ EPS)

$1.43M

-$0.07

Implied change from Q4 25 (Revenue/ EPS)

Implied change from Q1 25 (Revenue/ EPS)

-50.00%

Iterum Therapeutics plc Ordinary Share earnings per share and revenue

On Feb 05, 2026, ITRM reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.14 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 515.10 thousand, with a --% difference.

Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 1.43 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Takeda Pharmaceutical Company Limited - ADR

Report Date

Jan 30, 2026 For Q3 26

Estimate

$34.44

Actual

$65.64

Surprise

+90.61%

FAQ

What were Iterum Therapeutics plc Ordinary Share's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Iterum Therapeutics plc Ordinary Share reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Iterum Therapeutics plc Ordinary Share's Q4 2025 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Iterum Therapeutics plc Ordinary Share expected to report next?

The next earning report is scheduled for May 11, 2026.

What are the forecasts for Iterum Therapeutics plc Ordinary Share's next earnings report?

Based on 3 analysts, Iterum Therapeutics plc Ordinary Share is expected to report EPS of -$0.07 and revenue of $1.43M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.